Transgenic Group Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2,134	2,555	2,478	3,459	4,618
Short-Term Investments	-	-	-	-	5
Cash & Short-Term Investments	2,134	2,555	2,478	3,459	4,623
Cash Growth	-16.48%	3.11%	-28.36%	-25.18%	52.57%
Receivables	1,166	1,211	1,336	1,076	893
Inventory	2,472	2,221	2,227	2,238	1,714
Other Current Assets	936	711	508	789	479
Total Current Assets	6,708	6,698	6,549	7,562	7,709
Property, Plant & Equipment	1,991	2,055	2,142	1,991	1,992
Long-Term Investments	362	246	264	230	234
Goodwill	484	531	512	557	365
Other Intangible Assets	21	22	21	10	12
Long-Term Deferred Tax Assets	167	31	321	320	126
Other Long-Term Assets	2	2	-	1	2
Total Assets	9,735	9,586	9,810	10,672	10,440
Accounts Payable	415	413	276	408	256
Accrued Expenses	64	69	71	23	16
Short-Term Debt	565	680	448	170	390
Current Portion of Long-Term Debt	571	538	466	492	337
Current Portion of Leases	-	-	15	17	16
Current Income Taxes Payable	279	275	282	341	724
Other Current Liabilities	1,954	1,297	876	1,292	920
Total Current Liabilities	3,848	3,272	2,434	2,743	2,659
Long-Term Debt	952	1,356	1,307	1,706	1,031
Long-Term Leases	-	-	19	31	44
Pension & Post-Retirement Benefits	70	68	37	40	24
Long-Term Deferred Tax Liabilities	17	12	-	-	-
Other Long-Term Liabilities	10	23	16	31	47
Total Liabilities	4,897	4,731	3,813	4,551	3,805
Common Stock	50	50	50	50	50
Additional Paid-In Capital	3,856	3,857	3,861	3,869	4,109
Retained Earnings	850	927	2,067	2,147	2,657
Treasury Stock	-116	-116	-135	-76	-300
Comprehensive Income & Other	139	44	50	27	15
Total Common Equity	4,779	4,762	5,893	6,017	6,531
Minority Interest	59	93	104	104	104
Shareholders' Equity	4,838	4,855	5,997	6,121	6,635
Total Liabilities & Equity	9,735	9,586	9,810	10,672	10,440
Total Debt	2,088	2,574	2,255	2,416	1,818
Net Cash (Debt)	46	-19	223	1,043	2,805
Net Cash Growth	-	-	-78.62%	-62.82%	170.49%
Net Cash Per Share	2.76	-1.14	13.27	61.92	163.41
Filing Date Shares Outstanding	16.65	16.65	16.59	16.86	16.82
Total Common Shares Outstanding	16.65	16.65	16.59	16.86	16.82
Working Capital	2,860	3,426	4,115	4,819	5,050
Book Value Per Share	286.97	285.95	355.13	356.93	388.34
Tangible Book Value	4,274	4,209	5,360	5,450	6,154
Tangible Book Value Per Share	256.65	252.74	323.01	323.29	365.92
Order Backlog	2,580	3,001	1,956	2,791	2,581